J. Gérard

发表

Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2.

T. Conroy, A. Leroux, I. Soubeyran, 2013, European journal of cancer.

Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.

R. Écochard, P. Maingon, P. Romestaing, 2013, International journal of radiation oncology, biology, physics.

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

T. Conroy, M. Ducreux, D. Peiffert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A topographic approach to breast cancer. The relation of topographic and mammographic findings

J. Gérard, C. Bailly, P. Noël, 1977, Cancer.

XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma.

S. Hehlgans, F. Rödel, B. Flourié, 2012, The American journal of pathology.

Biophysical modelling: implications for conformation radiation treatment

C. Ling, J. Gérard, 1993 .

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Bernard Leduc, Franck Bonnetain, Olivier Bouché, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials.

L. Collette, J. van Soest, A. Dekker, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of radiotherapy in the treatment of rectal cancer in older patients.

J. Gérard, A. Myint, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Immunotherapy for rectal carcinoma: Some stimulating data but still a long way to clinical evidence.

J. Gérard, J. Doyen, 2016, European journal of cancer.

Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial.

E. Cotte, E. Decullier, J. Gérard, 2016, International journal of radiation oncology, biology, physics.

Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial.

V. Boige, S. Gourgou-Bourgade, J. Gérard, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy.

T. Conroy, S. Gourgou-Bourgade, M. Jarlier, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer

T. Beißbarth, C. Plass, A. Leha, 2014, Oncotarget.

Aims of combined modality therapy in rectal cancer (M0).

J. Gérard, K. Bénézery, E. François, 2014, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Clinical outcome of rectal cancer in patients ≥ 80 years treated in southern France (PACA region) between 2002 and 2005

J. Gérard, O. Guerin, J. Gal, 2012, Strahlentherapie und Onkologie.

Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.

P. Romestaing, J. Gérard, O. Chapet, 2012, International journal of radiation oncology, biology, physics.

What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?

L. Collette, G. Calais, T. Conroy, 2012, European journal of cancer.

Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

T. Conroy, Y. Bécouarn, O. Bouché, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of response in rectal cancer: we are still far from the "crystal ball".

J. Gérard, E. François, 2010, Digestive and Liver Disease.

Contact X-Ray Therapy

J. Gérard, R. Myerson, A. Myint, 2010 .

Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trial.

T. Conroy, M. Ducreux, O. Bouché, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

State of the art and recent advance in the treatment of resectable nonmetastatic rectal cancer.

J. Gérard, K. Bénézery, E. François, 2007, Surgical oncology.

French experience with contact X-ray endocavitary radiation for early rectal cancer.

P. Romestaing, J. Gérard, O. Chapet, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Update on neoadjuvant strategies for rectal cancer patients

J. Gérard, E. François, 2007 .

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.

P. Adeleine, J. Gérard, C. Némoz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.

P. Adeleine, P. Maingon, P. Romestaing, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Estro Regaud Lecture. Radiotherapy in the conservative treatment of rectal cancer. Evidence-based medicine and opinion.

J. Gérard, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy.

J. Gérard, J. Orgiazzi, R. Mornex, 1987, Hormone Research.

Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer.

F. Eschwège, J. Gérard, H. Sancho-garnier, 1988, NCI monographs : a publication of the National Cancer Institute.

Clinical and research validity of hadrontherapy with ion beams.

R. Orecchia, J. Gérard, M. Krengli, 2004, Critical reviews in oncology/hematology.

Contact radiotherapy using a 50 kV X-ray system: Evaluation of relative dose distribution with the Monte Carlo code PENELOPE and comparison with measurements

S. Marcié, Olivier Croce, J. Gérard, 2012 .

Radiotherapy alone in the curative treatment of rectal carcinoma.

P. Romestaing, J. Gérard, O. Chapet, 2003, The Lancet. Oncology.

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study

G. Beets, R. Beets-Tan, A. Vahrmeijer, 2018, The Lancet.

A systematic review comparing radiation toxicity after various endorectal techniques.

F. Verhaegen, M. Berbée, J. Gérard, 2019, Brachytherapy.

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

T. Conroy, Y. Bécouarn, O. Bouché, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Structured and shared MRI staging lexicon and report of rectal cancer: A consensus proposal by the French Radiology Group (GRERCAR) and Surgical Group (GRECCAR) for rectal cancer.

I. Petkovska, S. Nougaret, E. Cotte, 2021, Diagnostic and interventional imaging.

An analysis of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer on survival in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?

L. Collette, G. Calais, T. Conroy, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of single‐nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD‐12/PRODIGE‐2 phase III trial

P. Laurent-Puig, V. Boige, J. Gérard, 2019, International journal of cancer.

Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.

S. Marcié, J. Gugenheim, J. Gérard, 2017, European journal of cancer.

New Neoadjuvant Treatment Strategies for Non-Metastatic Rectal Cancer (M0)

J. Gérard, J. Doyen, N. Barbet, 2015, Current Colorectal Cancer Reports.

Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

P. Romestaing, J. Gérard, F. Mornex, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sphincter and rectal preservation approaches for early stage distal rectal cancers

P. Marcy, J. Gérard, E. François, 2006 .

Present treatment of rectal adenocarcinoma

J. Gérard, O. Thomas, C. Ortholan, 2004 .

Radiochemotherapy in rectal cancer: the role of oxaliplatin

C. V. D. van de Velde, R. Glynne-Jones, J. Gérard, 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Local curative treatment of rectal cancer by radiotherapy alone

P. Romestaing, J. Gérard, J. Baulieux, 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone.

A. Ramaioli, P. Romestaing, J. Gérard, 2002, International journal of radiation oncology, biology, physics.

Functional results of delayed coloanal anastomosis after preoperative radiotherapy for lower third rectal cancer.

J. Gérard, M. Adham, C. Ducerf, 2000 .

[Rectal cancer: The radiation basis of radiotherapy, target volume].

J. Bosset, C. Hennequin, J. Gérard, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

Christophe Hennequin, Bernard Denis, Pierre-Luc Etienne, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renaissance of contact x-ray therapy for treating rectal cancer

S. Marcié, Olivier Croce, J. Gérard, 2011, Expert review of medical devices.

Reply to M. Mohiuddin et al

J. Gérard, 2011 .

ACCORD12/0405-Prodige 2 Phase III Trial Neoadjuvant Treatment in Rectal Cancer: Results after 3 Years of Follow-up

T. Conroy, P. Romestaing, S. Gourgou-Bourgade, 2011 .

Reply to R. Glynne-Jones

J. Gérard, 2011 .

Rectal Cancer: Rectal Preservation Is an Important End Point

G. Milano, J. Gérard, G. Freyer, 2010 .

Prognostic value of P53 mutations in rectal carcinoma

G. Thomas, P. Laurent-Puig, R. Hamelin, 2002, International journal of cancer.

Gastric IORT With or Without EBRT

F. Guillemin, J. Gérard, F. Calvo, 1999 .

GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer

T. Rockall, F. Verhaegen, T. Vuong, 2021, Clinical and translational radiation oncology.

Contact X-Ray Brachytherapy for Rectal Cancer

J. Gérard, R. Myerson, A. Myint, 2015 .

Radiotherapy in cancer pain management

J. Gérard, C. Ortholan, J. Nebbia, 2005 .

Pattern of failures in gastric cancer patients with lymph node involvement treated by surgery, intraoperative and external beam radiotherapy.

P. Romestaing, J. Gérard, O. Chapet, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients).

A. Gerbaulet, F. Baillet, J. Gérard, 1992, International Journal of Radiation Oncology, Biology, Physics.

Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function.

J. Thariat, G. Poissonnet, A. Bozec, 2009, International journal of radiation oncology, biology, physics.

A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

J. Galon, F. Bibeau, R. Perez, 2020, Clinical Cancer Research.

Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?

P. Romestaing, J. Gérard, F. Mornex, 2005, International journal of radiation oncology, biology, physics.

Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers: Preliminary results of the FFCD 9203 randomized trial

T. Conroy, M. Déjardin, J. Bosset, 2004 .

Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.

R. Schiappa, J. Gugenheim, J. Gérard, 2019, European journal of cancer.

Contact X-ray brachytherapy for rectal cancer: Past, present, and future.

J. Gérard, J. Hannoun-levi, C. Dejean, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Significance of Local Tumor Control

M. Cucherat, J. Gérard, P. Roy, 2000 .

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.

P. Romestaing, Y. Lehingue, J. Gérard, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radiotherapy for elderly patients with breast cancer.

A. Courdi, J. Gérard, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Results of High Doses of External Radiotherapy for Age-Related Macular Degeneration with Subfoveal Neovascularization

J. Gérard, M. Mauget-Faÿsse, R. Coquard, 2001 .

[Past, present and near future of techniques in radiation oncology].

P. Giraud, J. Thariat, J. Cosset, 2010, Bulletin du cancer.

[Current situation and perspectives of proton therapy].

P. Bondiau, J. Thariat, J. Habrand, 2015, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Corrigendum to "2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer" [Eur J Cancer 63 (August 2016) 11-24].

D. Aust, I. Nagtegaal, K. Haustermans, 2016, European journal of cancer.

Differential expression of growth factors in irradiated mouse testes.

M. Benahmed, C. Mauduit, A. Siah, 2001, International journal of radiation oncology, biology, physics.

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.

T. Petit, P. Quétin, P. Romestaing, 2007, Gynecologic oncology.

Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers: Preliminary results of the FFCD 9203 randomized trial.

T. Conroy, J. Bosset, O. Bouché, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative concurrent chemoradiation in locally advanced rectal cancer with 50 Gy and oxaliplatin (OXA), fluorouracil (FU), I-folinic acid (l-LV). The lyon R0-04 phase II trial

P. Romestaing, J. Gérard, F. Mornex, 2002 .

Primary carcinoma of the gall-bladder: potential for external radiation therapy.

P. Romestaing, J. Gérard, M. Mahé, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Preoperative radiotherapy of rectal cancer. The Lyons experience, 1985-1996. Prognostic study apropos of 312 patients].

E. Morignat, P. Romestaing, J. Gérard, 1999, Annales de chirurgie.

Role of radiotherapy in anal preservation for cancers of the lower third of the rectum.

J. Papillon, J. Gérard, 1990, International journal of radiation oncology, biology, physics.

[Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation].

P. Romestaing, J. Gérard, O. Chapet, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.

J. Pignon, T. Conroy, M. Ducreux, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV

T. Vuong, J. Gérard, J. Gal, 2022, Cancers.

Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer

R. Schiappa, J. Gérard, K. Bénézery, 2022, Clinical and translational radiation oncology.

Minimally invasive contact X-ray brachytherapy as an alternative option in patients with rectal cancer not suitable for bespoke surgical resection

J. Gérard, A. Myint, 2018, Mini-invasive Surgery.

Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03).

D. Peiffert, P. Romestaing, B. Denis, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Feasibility and early toxicity of intraoperative radiotherapy for breast cancer using the papillon + system: First results

J. Gérard, C. Colnard, E. Barranger, 2022, Clinical and translational radiation oncology.

Curative external beam radiotherapy for prostate carcinoma: results in 231 patients treated in Lyon.

P. Romestaing, J. Gérard, F. Mornex, 1999, The Australian and New Zealand journal of surgery.

Prognostic factors in chordoma: role of postoperative radiotherapy.

J. Blay, P. Biron, J. Gérard, 1995, European journal of cancer.

Differential effects of ionizing radiation and platinum-derivative chemotherapy on apoptotic pathways in testicular germ cells

M. Benahmed, C. Mauduit, P. Romestaing, 2007, International journal of radiation biology.

The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.

D. Cox, P. Pisani, P. Romestaing, 2006, Carcinogenesis.

The XRCC 1 77 T ! C variant : haplotypes , breast cancer risk , response to radiotherapy and the cellular response to DNA damage

D. Cox, P. Pisani, P. Romestaing, 2006 .

Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of toxicities in a French center.

J. Gérard, F. Mornex, O. Chapet, 2011, Journal of clinical gastroenterology.

High dose-high precision in radiation oncology.

J. Gérard, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiation therapy in extrahepatic bile duct carcinoma.

P. Romestaing, J. Gérard, M. Mahé, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Bronchoalveolar lavage in radiation pneumonitis.

J. Gérard, J. Cordier, J. Mornex, 1984, Bulletin europeen de physiopathologie respiratoire.

The importance of measuring baseline tumour volume (or alternatively tumour length along with its rectal circumferential extent) in the watch-and-wait strategy in rectal cancer: a review

K. Bujko, J. Gérard, A. Hołdakowska, 2022, Acta oncologica.

Preoperative Chemoradiotherapy (CT-RT) Improves Local Control in T3-4 Rectal Cancers: Results of the FFCD 9203 Randomized Trial

T. Conroy, O. Bouché, P. Romestaing, 2005 .

Surgical management of retroperitoneal sarcomas associated with external and intraoperative electron beam radiotherapy.

P. Romestaing, J. Gérard, O. Chapet, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Combined curative radiation therapy alone in (T1) T2-3 rectal adenocarcinoma: a pilot study of 29 patients.

J. Thalabard, P. Romestaing, J. Gérard, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Primary Squamous-Cell Carcinoma of the Rectum

J. Gérard, F. Gilly, J. Baulieux, 2002, Diseases of the colon and rectum.

[Therapeutic risk in multidisciplinary approach of cerebral arteriovenous malformations].

C. Mottolese, J. Gérard, F. Turjman, 1996, Neuro-Chirurgie.

Adenocarcinoma of the Body and Tail of the Pancreas: Is There Room for Adjuvant Radiotherapy?

P. Romestaing, J. Gérard, F. Gilly, 1997, Tumori.

[State of the art and advances in radiotherapy for bladder cancer].

P. Bondiau, M. Housset, J. Thariat, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.

M. Bollet, D. Peiffert, J. Gérard, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Role of Combined Radiochemotherapy: The Lyon Experience

J. Papillon, J. Gérard, J. Ardiet, 1991 .

Prognostic factors for local control in recurrent cervical carcinoma treated with IORT: report of the French IORT Group.

F. Guillemin, P. Romestaing, J. Gérard, 1997, Frontiers of radiation therapy and oncology.

Pilot study of IORT for bladder carcinoma.

J. Gérard, F. Gilly, I. Sentenac, 1997, Frontiers of radiation therapy and oncology.

Multidisciplinary treatment of cerebral arteriovenous malformations.

C. Mottolese, J. Gérard, F. Turjman, 1995, Neurological research.

Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud – Nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients

S. Marcié, P. Romestaing, J. Gérard, 2015, Acta oncologica.

Adjuvant and neoadjuvant radiation therapy for rectal cancer.

J. Horiot, J. Bosset, J. Gérard, 2000, Seminars in oncology.

[Treatment of eyelid carcinomas of 2 cmm or less by contact radiotherapy].

A. Pica, P. Romestaing, J. Gérard, 1996, Journal francais d'ophtalmologie.

[Double irradiation for macroscopic radioresistance or recurrence of melanomas of the posterior uvea: clinical, ballistic, therapeutic and prognostic aspects. Series of 19 cases among 462 patients].

J. Gérard, P. Chauvel, D. Brănișteanu, 1999, Journal francais d'ophtalmologie.

Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique.

P. Romestaing, J. Gérard, F. Rocher, 1996, International journal of radiation oncology, biology, physics.

Conservative management of anal and rectal cancer. The role of radiation therapy.

P. Romestaing, J. Gérard, X. Montbarbon, 1989, Acta oncologica.

Interstitial curietherapy in the conservative treatment of anal and rectal cancers.

J. Papillon, J. Gérard, J. Ardiet, 1989, International journal of radiation oncology, biology, physics.

Past, present, and future of radiotherapy for the benefit of patients

Te Vuong, Juliette Thariat, T. Vuong, 2013, Nature Reviews Clinical Oncology.

[Chemoradiotherapy and anal canal cancer].

J. Gérard, E. François, C. Ortholan, 2005, Bulletin du cancer.

Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.

E. Touboul, A. Ramaioli, D. Peiffert, 2005, International journal of radiation oncology, biology, physics.

[Preneoplastic anal lesions and anal canal carcinoma].

J. Gérard, E. François, C. Ortholan, 2003, Bulletin du cancer.

Management of inguinal lymph node metastases in patients with carcinoma of the anal canal

E. Morignat, P. Romestaing, J. Gérard, 2001, Cancer.

Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience

P. Romestaing, J. Gérard, F. Mornex, 2006, International Journal of Colorectal Disease.

Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study).

D. Cowen, N. Salem, J. Gérard, 2012, International journal of radiation oncology, biology, physics.

High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study).

D. Cowen, N. Salem, J. Gérard, 2011, International journal of radiation oncology, biology, physics.

A new approach to the management of epidermoid carcinoma of the anal canal

J. Papillon, J. Gérard, C. Bailly, 1983, Cancer.

Effective use of argon plasma coagulation in the treatment of severe radiation proctitis

B. Flourié, J. Gérard, S. Nancey, 2001, Diseases of the colon and rectum.

151Can pilocarpine hydrochloride relieve xerostomia regardless of the destruction of major salivary glands? A prospective French cooperative study

J. Horiot, S. Schraub, G. Calais, 1996 .

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.

D. Cox, P. Pisani, W. Jongmans, 2003, Cancer research.

Towards a molecular classification of colorectal cancer

M. Ridder, J. Gérard, 2015 .

High-resolution analysis of DNA copy number alterations in rectal cancer

E. Letouzé, G. Milano, J. Gaedcke, 2014, Strahlentherapie und Onkologie.

Radiosensitivity of Colon and Rectal Lung Oligometastasis Treated With Stereotactic Ablative Radiotherapy

P. Bondiau, J. Gérard, A. Naghavi, 2017, Clinical colorectal cancer.

Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus

J. Gérard, F. Mornex, M. Adham, 2000, Cancer.

Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.

E. Letouzé, S. Olschwang, P. Romestaing, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Contact X-ray therapy for rectal cancer: experience in Centre Antoine-Lacassagne, Nice, 2002-2006.

J. Gérard, K. Bénézery, E. Chamorey, 2008, International journal of radiation oncology, biology, physics.

Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients.

F. Guillemin, F. Guillemin, J. Gérard, 1996, International journal of radiation oncology, biology, physics.

Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

P. Adeleine, P. Romestaing, J. Gérard, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials.

Vincenzo Valentini, Philippe Lambin, Laurence Collette, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IORT in pancreatic adenocarcinoma.

P. Romestaing, J. Gérard, I. Sentenac, 1997, Frontiers of radiation therapy and oncology.

Primary Squamous-Cell Carcinoma of the Rectum: Report of Six Cases and Review of the Literature

J. Gérard, F. Gilly, J. Baulieux, 2002 .

The use of radiotherapy for patients with low rectal cancer: an overview of the Lyon experience.

J. Gérard, 1994, The Australian and New Zealand journal of surgery.

Trends in tobacco smoking among adolescents in Lyon, France.

A. Sasco, J. Gérard, R. Merrill, 2003, European journal of cancer.

Commentary

P. Follana, J. Gérard, E. François, 2008 .

Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO).

T. Conroy, J. Bosset, O. Bouché, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.

R. Schiappa, L. Mineur, J. Gérard, 2023, The lancet. Gastroenterology & hepatology.

Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence

R. Schiappa, J. Gérard, K. Bénézery, 2020, Clinical and translational radiation oncology.

Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.

D. Cox, P. Romestaing, J. Gérard, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

IRIDIUM WIRE RADIOTHERAPY FOR HIGH BILEDUCT CARCINOMA

J. Gérard, F. Mornex, P. Bret, 1981, The Lancet.

Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy.

P. Romestaing, J. Gérard, J. Ardiet, 1998, International journal of radiation oncology, biology, physics.

Redifferentiation Therapy in Brain Tumors: Long-lasting Complete Regression of Glioblastomas and an Anaplastic Astrocytoma Under Long Term 1-alpha-hydroxycholecalciferol

J. Honnorat, A. Jouvet, P. Trouillas, 2004, Journal of Neuro-Oncology.

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.

D. Aust, I. Nagtegaal, K. Haustermans, 2016, European journal of cancer.

Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials.

J. Gérard, D. Benchimol, Y. Rostom, 2012, Critical reviews in oncology/hematology.

Randomized multicenter phase III trial comparing two neoadjuvant chemoradiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients (pts) with locally advanced rectal cancer (LARC): Results of the ACCORD 12/0405 PRODIGE 2.

T. Conroy, S. Gourgou-Bourgade, C. Hennequin, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-l-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer : Final results of a phase l i study ,

T. Conroy, M. Ducreux, D. Peiffert, 2005 .

Stereotactic radiosurgery for arteriovenous malformations of the brain using a standard linear accelerator: the Lyon experience.

A. Pica, P. Romestaing, J. Gérard, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.

Olga Anczuków, D. Thompson, G. Lenoir, 2004, Carcinogenesis.

PERATIVE ABSTRACTS of the XX PTCOG MEETING held in Chester , England May 16-18 1994

F., N. Bornfeld, F. Demard, 2008 .

Monte Carlo simulation of a medical linear accelerator for radiotherapy use.

B Serrano, J Barthe, J Hérault, 2006, Radiation protection dosimetry.

Partial breast irradiation: revolution or evolution?

H. Marsiglia, J. Gérard, J. Hannoun-levi, 2004, Cancer treatment reviews.

Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences.

Anthony J. Lopez, C. Lepage, V. Jooste, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Results of age-dependent anal canal cancer treatment: a single centre retrospective study.

P. Follana, J. Gérard, K. Bénézery, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cancers du rectum : volumes cible de la radiothérapie, bases rationnelles

J. Bosset, C. Hennequin, J. Gérard, 2011 .

Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer.

O. Nanni, S. Wexner, R. Audisio, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Implications of learning effects for hospital costs of new health technologies: The case of intensity modulated radiation therapy

G. de Pouvourville, J. Bourhis, D. Lefkopoulos, 2007, International Journal of Technology Assessment in Health Care.

Predictive Factors for Early and Late Local Toxicities in Anal Cancer Treated by Radiotherapy in Combination With or Without Chemotherapy

P. Follana, J. Gérard, K. Bénézery, 2013, Diseases of the colon and rectum.

Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).

J. Gérard, L. Kodjikian, P. Roy, 2004, American journal of ophthalmology.

Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration

C. Chiquet, D. Milea, P. Romestaing, 1999, The British journal of ophthalmology.

[Radiotherapy for age-related macular degeneration: risk factors of complications, prevention and treatment of side-effects].

J. Romanet, D. Milea, P. Romestaing, 2000, Journal francais d'ophtalmologie.

Endocavitary radiation therapy

P. Romestaing, J. Gérard, F. Mornex, 1998 .

Sphincter preservation in rectal cancer. Endocavitary radiation therapy.

P. Romestaing, J. Gérard, F. Mornex, 1998, Seminars in radiation oncology.

The role of radiotherapy in the conservative treatment of rectal carcinoma--the Lyon experience.

P. Romestaing, J. Gérard, F. Mornex, 1998, Acta oncologica.

Conservative and curative management of rectal adenocarcinomas by local radiotherapy alone.

J. Horiot, P. Maingon, J. Gérard, 1995, European journal of cancer.

Interstitial high-dose rate brachytherapy as boost for anal canal cancer

J. Gérard, K. Bénézery, J. Hannoun-levi, 2014, Radiation oncology.

Reply to R. Glynne-Jones et al.

T. Conroy, M. Ducreux, D. Peiffert, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.

T. Conroy, M. Ducreux, D. Peiffert, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.

P. Romestaing, J. Gérard, F. Mornex, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast Cancer in Elderly Women: is Partial Breast Irradiation a Good Alternative?

M. Namer, A. Courdi, H. Marsiglia, 2003, Breast Cancer Research and Treatment.

The “Immunoscore” in rectal cancer: could we search quality beyond quantity of life?

T. Hansen, J. Galon, G. Beets, 2021, Oncotarget.

International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

K. Haustermans, G. Beets, C. Marijnen, 2021, Nature Reviews Clinical Oncology.

Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.

P. Romestaing, J. Gérard, F. Mornex, 2005, International journal of radiation oncology, biology, physics.

Treatment of squamous cell anal canal carcinoma with pulsed dose rate brachytherapy. Feasibility study of a French cooperative group.

B. Castelain, D. Peiffert, J. Gérard, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy of high bile duct carcinoma using intracatheter iridium 192 wire

J. Gérard, F. Mornex, P. Bret, 1984, Cancer.

Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery

J. van Soest, A. Dekker, J. Folkesson, 2022, Physics and imaging in radiation oncology.

Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: The 3-year results of OPERA randomized trial (NCT02505750).

N. Magné, L. Mineur, J. Gérard, 2022, Journal of Clinical Oncology.

The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.

L. Påhlman, M. Tonato, J. Tepper, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Whither papillon? Future directions for contact radiotherapy in rectal cancer.

S. Laurberg, J. Gérard, J. Lindegaard, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Overview Whither Papillon ? d Future Directions for Contact Radiotherapy in Rectal Cancer

S. Laurberg, J. Gérard, J. Lindegaard, 2022 .

Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor).

J. Bosset, J. Gérard, J. V. van Dijk, 1990, Seminars in liver disease.

ACCORD12/0405-Prodige 2 phase III trial neoadjuvant treatment in rectal cancer: Results after 5 years of follow-up.

T. Conroy, O. Bouché, S. Gourgou-Bourgade, 2016 .

[Role of peroperative radiotherapy in the treatment of uterine cancers. Preliminary experience in Lyon].

P. Adeleine, P. Romestaing, J. Gérard, 1994, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

Curative non-surgical combined treatment of squamous cell carcinoma of the oesophagus.

P. Romestaing, J. Gérard, R. Lambert, 1992, European journal of cancer.

Complications after multidisciplinary treatment of cerebral arteriovenous malformations

C. Mottolese, J. Gérard, F. Turjman, 2005, Acta Neurochirurgica.

Stereotactic radiosurgery: the Lyon experience.

P. Romestaing, J. Gérard, F. Rocher, 1995, Acta neurochirurgica. Supplement.

[Radionecrosis after curietherapy for anal carcinoma. Current methods of radiation therapy (author's transl)].

J. Papillon, J. Gérard, J. Chassard, 1979, Gastroenterologie clinique et biologique.

Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal

J. Gérard, K. Bénézery, J. Hannoun-levi, 2018, Journal of contemporary brachytherapy.

Interstitial high-dose rate brachytherapy as boost for anal canal cancer

J. Gérard, K. Bénézery, J. Hannoun-levi, 2014, Radiation Oncology.

Radiation therapy in the conservative treatment of carcinoma of the anal canal.

P. Romestaing, J. Gérard, M. Mahé, 1994, International journal of radiation oncology, biology, physics.

Overview of the role of preoperative radiotherapy to increase sphincter preservation for rectal cancer.

P. Romestaing, J. Gérard, O. Chapet, 2004, Frontiers of radiation therapy and oncology.

[Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0].

P. Romestaing, J. Gérard, F. Mornex, 2000, Gastroenterologie clinique et biologique.

What Is the Contribution of Brachytherapy in Tailoring Local Therapy

T. Vuong, J. Gérard, J. Hannoun-levi, 2012 .

Role of contact x-ray brachytherapy ( CXB ) for rectal cancer : current status and challenges

J. Gérard, K. Bénézery, J. Hannoun-levi, 2010 .

[Iridium curietherapy in conservative treatment of infiltrating cancer of the bladder].

P. Romestaing, J. Gérard, J. Auque, 1985, Journal d'urologie.

Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer.

P. Lambin, L. Collette, J. Bosset, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Conservative treatment of early carcinoma of the breast: significance of axillary dissection and iridium implant.

J. Papillon, P. Romestaing, J. Gérard, 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Intensity modulated radiotherapy (IMRT) in France: The boost of the national funding for the new expensive innovative technologies (STIC 2001 and 2002)].

J. Gérard, R. Bensadoun, M. Carrère, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Curative treatment of carcinoma of the prostate with an association of external irradiation, iridium implant and lymphadenectomy.

P. Romestaing, J. Gérard, F. Mornex, 1987, Progress in clinical and biological research.

Does non-TME surgery of rectal cancer compromise the chance of cure? Preliminary surgical salvage data from OPERA phase III randomized trial.

J. Gérard, A. Myint, B. Thamphya, 2021 .

Report of Six Cases and Review of the Literature

J. Gérard, F. Gilly, J. Baulieux, 2002 .

MRI restaging of rectal cancer: The RAC (Response-Anal canal-CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups.

I. Petkovska, O. Catalano, S. Nougaret, 2023, Diagnostic and interventional imaging.

[Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].

P. Romestaing, J. Gérard, F. Mornex, 1997, Bulletin du cancer.

Pathological Response Is a Marker But Not a Cause of Good Prognosis in Rectal Cancer: 15-year Follow-up of the Lyon R90-01 Randomized Trial

E. Cotte, E. Decullier, J. Gérard, 2015 .

[Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy].

F. Chauvin, J. Gérard, M. Devonec, 1996, Bulletin du cancer.

pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients—An Updated Pooled Analysis of Eleven International Randomized Trials

J. van Soest, A. Dekker, C. Rödel, 2023, Cancers.

Management of uveal melanoma

J. Gérard, G. Laroche, I. Sentenac, 2004, International Ophthalmology.

Cerebral metastases as first symptom of bronchogenic carcinoma. A prospective study of 37 cases

M. Sindou, B. Croisile, G. Aimard, 1991 .

Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study

F. Berrino, G. Gatta, J. Faivre, 2007, Journal of cancer survivorship : research and practice.

Role of brachytherapy in treatment of epidermoid carcinomas of the vallecula after conservative supraglottic laryngectomy followed by irradiation.

J. Gérard, P. Pommier, P. Céruse, 2002, International journal of radiation oncology, biology, physics.

[Radiotherapy of malpighian cancers of the anus. Role of interstitial curietherapy, alone or combined with cobalt therapy, in the treatment of epidermoid cancers of the anus].

J. Papillon, J. Gérard, J. Chassard, 1973, Journal de radiologie, d'electrologie, et de medecine nucleaire.

Radiation therapy in proliferative vitreoretinopathy

J. Gérard, S. Binder, M. Bonnet, 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[Guide for external beam radiotherapy. Procedures 2007].

I. Barillot, J. Gérard, C. Ortholan, 2007, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy.

S. Marcié, J. Herault, J. Gérard, 2005, International journal of radiation oncology, biology, physics.

Regarding Minsky, IJROBP 34:961-962; 1996.

J. Gérard, 1996, International journal of radiation oncology, biology, physics.

[Radiation oncology training in France: demography, analysis of motivations of the young specialists, evaluation of the training].

L. Quéro, J. Gérard, G. Kantor, 2005, Cancer Radiothérapie.

Training curriculum in oncology in France. Conseil des Enseignants de Radiothérapie Oncologie (CERO).

J. Gérard, N. Daly, 1992, International Journal of Radiation Oncology, Biology, Physics.

Training curriculum in oncology in France

J. Gérard, N. Daly, 1992 .

[Radiotherapy of cancer of the anal canal. 15 years experience at the Lyon civil hospices and brief review of the literature].

E. Morignat, P. Romestaing, J. Gérard, 1998, Annales de Chirurgie.

A brief history of contact X-ray brachytherapy 50 kVp.

J. Gérard, K. Bénézery, C. Dejean, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Innovative image-guided CyberKnife stereotactic radiotherapy for bladder cancer.

P. Bondiau, J. Thariat, J. Gérard, 2010, The British journal of radiology.

[Neoadjuvant approach for non-metastatic rectal cancer combining radiotherapy and chemotherapy. Biotargeted drugs].

G. Milano, J. Gérard, K. Bénézery, 2009, Bulletin du Cancer.

[Oncologic and functional results of resections with direct delayed coloanal anastomosis in previously irradiated cancers of the lower rectum].

J. Gérard, M. Adham, C. Ducerf, 1999, Chirurgie; memoires de l'Academie de chirurgie.

Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique.

F. Chauvin, P. Romestaing, P. Fournel, 1990, International journal of radiation oncology, biology, physics.

Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT).

F. Chauvin, P. Romestaing, P. Fournel, 1993, Lung cancer.

[Good knowledge and respect for dosage tolerance of organs at risk and healthy tissues is one of the major aspects of the profession of radiotherapeutic oncology].

J. Gérard, C. Ortholan, Y. Pointreau, 2010, Cancer Radiothérapie.

T. Conroy, S. Gourgou-Bourgade, C. Hennequin, 2009, Journal of Clinical Oncology.

Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials.

J. Gérard, D. Benchimol, Y. Rostom, 2012, Critical reviews in oncology/hematology.

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

T. Conroy, M. Ducreux, D. Peiffert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 study).

D. Cowen, N. Salem, J. Gérard, 2011, International journal of radiation oncology, biology, physics.

Recurrences of rectal cancers: results of a multimodal approach with intraoperative radiation therapy. French Group of IORT. Intraoperative Radiation Therapy.

P. Rouanet, J. Gérard, M. Mahé, 1996, International journal of radiation oncology, biology, physics.

PRODIGE 2 phase III trial neoadjuvant in rectal cancer: Quality of life and results at 5 years.

T. Conroy, P. Rouanet, O. Bouché, 2016 .

Ten-year results of the Lyon R96-2 randomized trial in distal rectal cancer: Radiation dose escalation to increase organ preservation.

P. Romestaing, J. Gérard, O. Chapet, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Tumor Response after Neoadjuvant Radiotherapy in Rectal Cancer and Conservative Treatment: Ten Years Results of the Lyon R96-02 Randomized Trial

P. Romestaing, J. Gérard, O. Chapet, 2011 .

Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers: Preliminary results of the FFCD 9203 randomized trial.

T. Conroy, J. Bosset, O. Bouché, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

J. Thariat, G. Poissonnet, A. Bozec, 2009, International journal of radiation oncology, biology, physics.

Clinical results at 3 years of the ACCORD 12 randomized trial in rectal cancer.

T. Conroy, S. Gourgou-Bourgade, J. Gérard, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.